• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在疫苗短缺期间优化新冠疫苗接种计划。

Optimizing COVID-19 vaccination programs during vaccine shortages.

作者信息

Liu Kaihui, Lou Yijun

机构信息

Institute of Applied System Analysis, Jiangsu University, Zhenjiang, Jiangsu, 212013, PR China.

Department of Applied Mathematics, Hong Kong Polytechnic University, Hong Kong, China.

出版信息

Infect Dis Model. 2022 Mar;7(1):286-298. doi: 10.1016/j.idm.2022.02.002. Epub 2022 Feb 25.

DOI:10.1016/j.idm.2022.02.002
PMID:35233475
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8872681/
Abstract

During the ongoing COVID-19 pandemic, vaccine shortages occur due to various types of constraints, including interruptions in production/supply, higher-than-expected demands, and a lack of resources such as healthcare capacity to administer vaccines. Scientifically informed epidemic models have been utilized as pivotal tools to optimize the immunization programs subject to vaccine shortages. The current paper reviews modelling methods to optimize the allocation strategies of vaccines with differential efficacies by using various model-based outcome measures. The models reviewed in this study are expected to be adopted and extended to make contributions on policy development for disease control under the vaccine shortage scenario.

摘要

在当前的新冠疫情期间,由于各种限制因素,包括生产/供应中断、需求高于预期以及缺乏诸如医疗保健能力等资源来接种疫苗,导致了疫苗短缺。科学的疫情模型已被用作关键工具,以优化在疫苗短缺情况下的免疫计划。本文回顾了通过使用各种基于模型的结果指标来优化不同效力疫苗分配策略的建模方法。预计本研究中所回顾的模型将被采用和扩展,以在疫苗短缺情况下为疾病控制的政策制定做出贡献。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/120b/8907672/a34e2657a243/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/120b/8907672/80da151ec6f6/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/120b/8907672/a34e2657a243/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/120b/8907672/80da151ec6f6/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/120b/8907672/a34e2657a243/gr2.jpg

相似文献

1
Optimizing COVID-19 vaccination programs during vaccine shortages.在疫苗短缺期间优化新冠疫苗接种计划。
Infect Dis Model. 2022 Mar;7(1):286-298. doi: 10.1016/j.idm.2022.02.002. Epub 2022 Feb 25.
2
Optimizing two-dose vaccine resource allocation to combat a pandemic in the context of limited supply: The case of COVID-19.优化两剂疫苗资源分配以应对有限供应情况下的大流行:以 COVID-19 为例。
Front Public Health. 2023 Apr 24;11:1129183. doi: 10.3389/fpubh.2023.1129183. eCollection 2023.
3
A 5-year look-back at the notification and management of vaccine supply shortages in Germany.回顾德国疫苗供应短缺的通知和管理:5 年数据
Euro Surveill. 2022 Apr;27(17). doi: 10.2807/1560-7917.ES.2022.27.17.2100167.
4
Are vaccine shortages a relevant public health issue in Europe? Results from a survey conducted in the framework of the EU Joint Action on Vaccination.疫苗短缺在欧洲是一个相关的公共卫生问题吗?欧盟疫苗接种联合行动框架内一项调查的结果。
Vaccine. 2022 Mar 18;40(13):1987-1995. doi: 10.1016/j.vaccine.2022.02.041. Epub 2022 Feb 19.
5
Vaccine shortages: history, impact, and prospects for the future.疫苗短缺:历史、影响及未来展望
Annu Rev Public Health. 2006;27:235-59. doi: 10.1146/annurev.publhealth.27.021405.102248.
6
Comparison of health-oriented cross-regional allocation strategies for the COVID-19 vaccine: a mathematical modelling study.面向健康的 COVID-19 疫苗跨区域分配策略比较:一项数学建模研究。
Ann Med. 2022 Dec;54(1):941-952. doi: 10.1080/07853890.2022.2060522.
7
Targeted Vaccine Allocation Could Increase the COVID-19 Vaccine Benefits Amidst Its Lack of Availability: A Mathematical Modeling Study in Indonesia.在新冠疫苗供应不足的情况下,有针对性的疫苗分配可增加其效益:印度尼西亚的一项数学建模研究
Vaccines (Basel). 2021 May 6;9(5):462. doi: 10.3390/vaccines9050462.
8
Current situation, causes, and countermeasures to NIP vaccine shortages in Guangzhou, China.中国广州市 NIP 疫苗短缺的现状、原因及对策。
Hum Vaccin Immunother. 2020;16(1):76-79. doi: 10.1080/21645515.2019.1644883. Epub 2019 Aug 12.
9
Potential impact of introducing vaccines against COVID-19 under supply and uptake constraints in France: A modelling study.在供应和接种率的限制下,引入 COVID-19 疫苗对法国的潜在影响:一项建模研究。
PLoS One. 2021 Apr 28;16(4):e0250797. doi: 10.1371/journal.pone.0250797. eCollection 2021.
10
Within-country age-based prioritisation, global allocation, and public health impact of a vaccine against SARS-CoV-2: A mathematical modelling analysis.针对 SARS-CoV-2 的疫苗在国内的年龄优先排序、全球分配和对公共卫生的影响:一项数学建模分析。
Vaccine. 2021 May 21;39(22):2995-3006. doi: 10.1016/j.vaccine.2021.04.002. Epub 2021 Apr 8.

引用本文的文献

1
A network-based model to assess vaccination strategies for the COVID-19 pandemic by using Bayesian optimization.一种基于网络的模型,用于通过贝叶斯优化评估针对新冠疫情的疫苗接种策略。
Chaos Solitons Fractals. 2024 Apr;181. doi: 10.1016/j.chaos.2024.114695. Epub 2024 Mar 14.
2
Analyzing greedy vaccine allocation algorithms for metapopulation disease models.分析用于集合种群疾病模型的贪婪疫苗分配算法。
PLoS Comput Biol. 2025 Jul 21;21(7):e1012539. doi: 10.1371/journal.pcbi.1012539. eCollection 2025 Jul.
3
Patterns and Predictors of COVID-19 Vaccine Uptake Among U.S. Active Duty Service Members, 2020-2022: Implications for Future Pandemics.

本文引用的文献

1
Modeling waning and boosting of COVID-19 in Canada with vaccination.利用疫苗接种建模加拿大 COVID-19 的衰减和增强。
Epidemics. 2022 Jun;39:100583. doi: 10.1016/j.epidem.2022.100583. Epub 2022 May 25.
2
Modeling comparative cost-effectiveness of SARS-CoV-2 vaccine dose fractionation in India.建模 SARS-CoV-2 疫苗剂量分割在印度的比较成本效益。
Nat Med. 2022 May;28(5):934-938. doi: 10.1038/s41591-022-01736-z. Epub 2022 Feb 24.
3
Strategies for COVID-19 vaccination under a shortage scenario: a geo-stochastic modelling approach.
2020 - 2022年美国现役军人中新冠病毒疫苗接种模式及预测因素:对未来大流行的启示
Mil Med. 2025 Apr 23;190(5-6):1243-1252. doi: 10.1093/milmed/usaf004.
4
Unraveling the effects of the Ebola experience on behavior choices during COVID-19 in Liberia: a mixed-methods study across successive outbreaks.剖析埃博拉疫情经历对利比里亚新冠疫情期间行为选择的影响:一项针对连续疫情的混合方法研究
BMC Glob Public Health. 2024 Apr 1;2(1):22. doi: 10.1186/s44263-024-00054-5.
5
Impact of vaccination on Omicron's escape variants: Insights from fine-scale modelling of waning immunity in Hong Kong.疫苗接种对奥密克戎逃逸变体的影响:来自香港免疫力下降精细尺度模型的见解
Infect Dis Model. 2024 Sep 16;10(1):129-138. doi: 10.1016/j.idm.2024.09.006. eCollection 2025 Mar.
6
Dynamic Vaccine Allocation for Control of Human-Transmissible Disease.用于控制人传疾病的动态疫苗分配
Vaccines (Basel). 2024 Sep 9;12(9):1034. doi: 10.3390/vaccines12091034.
7
Learning from the COVID-19 pandemic: A systematic review of mathematical vaccine prioritization models.从新冠疫情中学习:数学疫苗优先排序模型的系统综述
Infect Dis Model. 2024 May 15;9(4):1057-1080. doi: 10.1016/j.idm.2024.05.005. eCollection 2024 Dec.
8
Impact assessment of self-medication on COVID-19 prevalence in Gauteng, South Africa, using an age-structured disease transmission modelling framework.利用年龄结构疾病传播建模框架评估南非豪登省自我用药对 COVID-19 流行的影响。
BMC Public Health. 2024 Jun 7;24(1):1540. doi: 10.1186/s12889-024-18984-y.
9
Learning from the COVID-19 pandemic: a systematic review of mathematical vaccine prioritization models.从新冠疫情中学习:数学疫苗优先级模型的系统综述
medRxiv. 2024 Mar 7:2024.03.04.24303726. doi: 10.1101/2024.03.04.24303726.
10
Perspectives on the COVID-19 Vaccination Rollout in 17 Countries: Reflexive Thematic and Frequency Analysis Based on the Strengths, Weaknesses, Opportunities, and Threats (SWOT) Framework.17 个国家对 COVID-19 疫苗接种工作的看法:基于优势、劣势、机会和威胁(SWOT)框架的反思性主题和频率分析。
JMIR Hum Factors. 2024 Feb 19;11:e44258. doi: 10.2196/44258.
短缺情况下的 COVID-19 疫苗接种策略:一种地理随机建模方法。
Sci Rep. 2022 Jan 31;12(1):1603. doi: 10.1038/s41598-022-05481-8.
4
Population homogeneity for the antibody response to COVID-19 BNT162b2/Comirnaty vaccine is only reached after the second dose across all adult age ranges.在所有成年年龄段,只有在接种第二剂 COVID-19 BNT162b2/Comirnaty 疫苗后,才能达到对抗体反应的人群同质性。
Nat Commun. 2022 Jan 10;13(1):140. doi: 10.1038/s41467-021-27761-z.
5
Global Percentage of Asymptomatic SARS-CoV-2 Infections Among the Tested Population and Individuals With Confirmed COVID-19 Diagnosis: A Systematic Review and Meta-analysis.全球检测人群和确诊 COVID-19 人群中无症状 SARS-CoV-2 感染比例的系统评价和荟萃分析。
JAMA Netw Open. 2021 Dec 1;4(12):e2137257. doi: 10.1001/jamanetworkopen.2021.37257.
6
BNT162b2 Vaccine Booster and Mortality Due to Covid-19.BNT162b2 疫苗加强针与新冠病毒导致的死亡率。
N Engl J Med. 2021 Dec 23;385(26):2413-2420. doi: 10.1056/NEJMoa2115624. Epub 2021 Dec 8.
7
Efficacy of booster doses in augmenting waning immune responses to COVID-19 vaccine in patients with cancer.在癌症患者中,加强针在增强对 COVID-19 疫苗的免疫应答方面的效果。
Cancer Cell. 2022 Jan 10;40(1):3-5. doi: 10.1016/j.ccell.2021.11.006. Epub 2021 Nov 16.
8
Potential impact of alternative vaccination strategies on COVID-19 cases, hospitalization, and mortality in Japan during 2021-2022.2021 - 2022年期间,替代疫苗接种策略对日本新冠肺炎病例、住院率和死亡率的潜在影响。
J Gen Fam Med. 2021 Aug 26;22(6):311-313. doi: 10.1002/jgf2.493. eCollection 2021 Nov.
9
Investigating the relationship between reopening the economy and implementing control measures during the COVID-19 pandemic.调查在 COVID-19 大流行期间经济重启与实施控制措施之间的关系。
Public Health. 2021 Nov;200:15-21. doi: 10.1016/j.puhe.2021.09.005. Epub 2021 Sep 11.
10
Immune responses to two and three doses of the BNT162b2 mRNA vaccine in adults with solid tumors.成年人实体瘤中接受两剂和三剂 BNT162b2 mRNA 疫苗的免疫反应。
Nat Med. 2021 Nov;27(11):2002-2011. doi: 10.1038/s41591-021-01542-z. Epub 2021 Sep 30.